REVIEW : Mesenchymal stem cell therapy for liver fibrosis

' REVIEW : Mesenchymal stem cell therapy for liver fibrosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • anti-fibrosis
  • immunemodulation
  • liver cirrhosis
  • mesenchymalstromalcells
  • trophic factors
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
242 0

0.0%

' REVIEW : Mesenchymal stem cell therapy for liver fibrosis' 의 참고문헌

  • Up-regulation of telomerase in primary cultured rat hepatocytes
    Nozawa K J Biochem 126 : 361 ~ 367 [1999]
  • Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis
    문경민 Clinical and Molecular Hepatology 19 (4) : 389 ~ 398 [2013]
  • Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse
    Zhang D PLoS One 6 : e16789 ~ [2011]
  • Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice
    Sakaida I Hepatology 40 : 1304 ~ 1311 [2004]
  • Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging
    Wang F Physiol Genomics 37 : 23 ~ 34 [2009]
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    홍원기 Clinical and Molecular Hepatology 19 (4) : 370 ~ 375 [2013]
  • The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
    Dai LJ Stem Cell Res 2 : 16 ~ 25 [2009]
  • The immunomodulatory capacity of mesenchymal stem cells
    Gebler A Trends Mol Med 18 : 128 ~ 134 [2012]
  • The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis
    Kim SU J Hepatol 57 : 556 ~ 563 [2012]
  • Targeted treatments for cirrhosis
    Fallowfield JA Expert Opin Ther Targets 8 : 423 ~ 435 [2004]
  • Studies on oxidative stress in liver diseases: important future trends in liver research
    Tanikawa K Med Mol Morphol 39 : 22 ~ 27 [2006]
  • Stem cells and liver repair
    Kung JW Curr Opin Biotechnol 20 : 568 ~ 574 [2009]
  • Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury:are we there yet?
    Kia R Br J Clin Pharmacol 75 : 885 ~ 896 [2013]
  • Stem cell therapies for liver failure and cirrhosis
    Zhang Z J Hepatol 59 : 183 ~ 185 [2013]
  • Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis:Egyptian study
    Amin MA Clin Transplant 27 : 607 ~ 612 [2013]
  • Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation:a pilot study
    Mudrabettu C Nephrology (Carlton) 20 : 25 ~ 33 [2015]
  • Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality
    Li X J Hepatol 36 : 488 ~ 493 [2002]
  • Proteomic techniques for characterisation of mesenchymal stem cell secretome
    Kupcova Skalnikova H. Biochimie 95 : 2196 ~ 2211 [2013]
  • Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk
    Cash WJ Hepatol Res 40 : 1098 ~ 1106 [2010]
  • Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications
    Yaghoubi SS Theranostics 2 : 374 ~ 391 [2012]
  • Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis
    El-Ansary M Stem Cell Rev 8 : 972 ~ 981 [2012]
  • Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
    Mohamadnejad M Arch Iran Med 10 : 459 ~ 466 [2007]
  • Oxidative stress-related molecules and liver fibrosis
    Parola M J Hepatol 35 : 297 ~ 306 [2001]
  • Oxidative stress and liver disease
    Zhu R Hepatol Res 42 : 741 ~ 749 [2012]
  • Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice
    Ghatak S Toxicol Appl Pharmacol 251 : 59 ~ 69 [2011]
  • No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients
    Sundin M Haematologica 92 : 1208 ~ 1215 [2007]
  • Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
    Ali G J Transl Med 10 : 75 ~ [2012]
  • Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells
    Lin N Life Sci 85 : 291 ~ 295 [2009]
  • NOX in liver fibrosis
    De Minicis S Arch Biochem Biophys 462 : 266 ~ 272 [2007]
  • Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells
    Schwartz RE J Clin Invest 109 : 1291 ~ 1302 [2002]
  • Models and mechanisms of fibrosis resolution
    Snowdon VK Alcohol Clin Exp Res 35 : 794 ~ 799 [2011]
  • Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
    Sharma RR Transfusion 54 : 1418 ~ 1437 [2014]
  • Mesenchymal stem cells suppress B-cell terminal differentiation
    Asari S Exp Hematol 37 : 604 ~ 615 [2009]
  • Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process
    Cho KA Cell Biol Int 36 : 1267 ~ 1274 [2012]
  • Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population
    Zhang B Blood 113 : 46 ~ 57 [2009]
  • Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
    Zhu W Exp Mol Pathol 80 : 267 ~ 274 [2006]
  • Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model
    Semedo P Stem Cells 27 : 3063 ~ 3073 [2009]
  • Mesenchymal stem cells as trophic mediators
    Caplan AI J Cell Biochem 98 : 1076 ~ 1084 [2006]
  • Mesenchymal stem cell-natural killer cell interactions:evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
    Spaggiari GM Blood 107 : 1484 ~ 1490 [2006]
  • Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure
    Parekkadan B PLoS One 2 : e941 ~ [2007]
  • Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression
    Rabani V Cell Biol Int 34 : 601 ~ 605 [2010]
  • Mechanisms of fibrogenesis
    Kisseleva T Exp Biol Med (Maywood) 233 : 109 ~ 122 [2008]
  • Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far?
    Haddad R Biomed Res Int 2014 : 216806 ~ [2014]
  • Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C
    Lichtinghagen R J Hepatol 34 : 239 ~ 247 [2001]
  • Management of fibrosis: the mesenchymal stromal cells breakthrough
    Usunier B Stem Cells Int 2014 : 340257 ~ [2014]
  • Liver-specific gene expression in mesenchymal stem cells is induced by liver cells
    Lange C World J Gastroenterol 11 : 4497 ~ 4504 [2005]
  • Liver regeneration after partial hepatectomy:critical analysis of mechanistic dilemmas
    Michalopoulos GK. Am J Pathol 176 : 2 ~ 13 [2010]
  • Liver from bone marrow in humans
    Theise ND Hepatology 32 : 11 ~ 16 [2000]
  • Liver fibrosis
    Bataller R J Clin Invest 115 : 209 ~ 218 [2005]
  • Isolation and characterization of bipotent liver progenitor cells from adult mouse
    Li WL Stem Cells 24 : 322 ~ 332 [2006]
  • Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis
    Volarevic V Autoimmunity 43 : 255 ~ 263 [2010]
  • Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms
    Wang J Hepatol Res 39 : 1219 ~ 1228 [2009]
  • Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide
    Ledda-Columbano GM Am J Pathol 139 : 1099 ~ 1109 [1991]
  • Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture
    Ong SY Biomaterials 27 : 4087 ~ 4097 [2006]
  • In vivo tracking of superparamagnetic iron oxide nanoparticle labeled chondrocytes in large animal model
    Chen J Ann Biomed Eng 40 : 2568 ~ 2578 [2012]
  • In vivo response of hepatocytes to growth factors requires an initial priming stimulus
    Webber EM Hepatology 19 : 489 ~ 497 [1994]
  • In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles
    Hu SL J Cell Biochem 108 : 529 ~ 535 [2009]
  • Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection : a phase I-II clinical trial
    Kharaziha P Eur J Gastroenterol Hepatol 21 : 1199 ~ 1205 [2009]
  • Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells
    Parekkadan B Biochem Biophys Res Commun 363 : 247 ~ 252 [2007]
  • Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming
    Najar M Stem Cell Rev 8 : 1188 ~ 1198 [2012]
  • Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients
    Zhang Z J Gastroenterol Hepatol 27 (Suppl 2) : 112 ~ 120 [2012]
  • Human neural stem cell grafts in the spinal cord of SOD1transgenic rats: differentiation and structural integration into the segmental motor circuitry
    Xu L J Comp Neurol 514 : 297 ~ 309 [2009]
  • Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion
    Sato Y Blood 106 : 756 ~ 763 [2005]
  • Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism
    Crisostomo PR Am J Physiol Cell Physiol 294 : C675 ~ C682 [2008]
  • Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal S Blood 105 : 1815 ~ 1822 [2005]
  • Human mesenchymal stem cells modulate B-cell functions
    Corcione A Blood 107 : 367 ~ 372 [2006]
  • Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential
    di Bonzo LV Gut 57 : 223 ~ 231 [2008]
  • Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis : a pilot study
    Jang YO Liver Int 34 : 33 ~ 41 [2014]
  • Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
    Si-Tayeb K Hepatology 51 : 297 ~ 305 [2010]
  • Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model
    Weber LW Crit Rev Toxicol 33 : 105 ~ 136 [2003]
  • Hepatocytes from non-hepatic adult stem cells
    Alison MR Nature 406 : 257 ~ [2000]
  • Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells
    Ivanov AV PLoS One 6 : e24957 ~ [2011]
  • Hepatitis C virus infection:molecular pathways to steatosis, insulin resistance and oxidative stress
    Clement S Viruses 1 : 126 ~ 143 [2009]
  • Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells
    Wang L Gastroenterology 143 : 1555.e2 ~ 1563.e2 [2012]
  • Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells
    Shu SN World J Gastroenterol 10 : 2818 ~ 2822 [2004]
  • Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver
    Baertschiger RM PLoS One 4 : e6657 ~ [2009]
  • Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord
    Yan J PLoS Med 4 : e39 ~ [2007]
  • Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation
    Marsden ER Lab Invest 67 : 427 ~ 433 [1992]
  • Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis
    Gladman M Curr Opin Neurol 25 : 735 ~ 742 [2012]
  • Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking
    Neri M Stem Cells 26 : 505 ~ 516 [2008]
  • Effects of standardized bilberry fruit extract (Mirtoselect®) on resolution of CCl4-induced liver fibrosis in mice
    Domitrovic R Food Chem Toxicol 49 : 848 ~ 854 [2011]
  • Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells
    Zhang W Stem Cells Dev 13 : 263 ~ 271 [2004]
  • Effect of mesenchymal stem cells on doxorubicin-induced fibrosis
    Mohammadi Gorji S Cell J 14 : 142 ~ 151 [2012]
  • Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing
    Chamberlain G Stem Cells 25 : 2739 ~ 2749 [2007]
  • Comparison of imaging techniques for tracking cardiac stem cell therapy
    Zhang SJ J Nucl Med 48 : 1916 ~ 1919 [2007]
  • Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis
    Healy BC Muscle Nerve 46 : 506 ~ 511 [2012]
  • Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells
    Amer ME Eur J Gastroenterol Hepatol 23 : 936 ~ 941 [2011]
  • Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs
    Raore B Spine (Phila Pa 1976) 36 : E164 ~ E171 [2011]
  • Cellular and molecular mechanisms of liver injury
    Malhi H Gastroenterology 134 : 1641 ~ 1654 [2008]
  • Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High)forkhead box P3+ regulatory T cells
    English K Clin Exp Immunol 156 : 149 ~ 160 [2009]
  • Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo
    Quintanilha LF Hepatol Res 44 : E206 ~ E217 [2014]
  • Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice
    Wu Y Int Wound J 11 : 701 ~ 710 [2014]
  • Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
    Augello A Eur J Immunol 35 : 1482 ~ 1490 [2005]
  • Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes
    Peng L Hepatology 54 : 820 ~ 828 [2011]
  • Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells
    Chen S Life Sci 89 : 975 ~ 981 [2011]